Roche Showcases Solutions for Laboratories of the Future
Posted on 30 Jul 2024
Roche (Basel, Switzerland) is showcasing a laboratory of the future exhibit at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo. Attendees can experience how Roche's growing portfolio of integrated systems and data solutions optimizes resources and simplifies and streamlines operations while driving better health outcomes.
Focusing on key attributes of science-based leadership, operational simplicity, and patient-centric partnership, Roche is featuring its newest innovations in-booth at ADLM. These include the future cobas Mass Spec solution designed to be a total end-to-end solution for clinical mass spectrometry testing with the goal of seamless integration into the routine laboratory. Roche is also highlighting the new CCM Vertical, a flexible modular system that uses lab space effectively and seamlessly integrates into the existing cobas connection modules. Also featuring at ADLM 2024 is the cobas liat system which brings gold-standard PCR technology to the point of care, providing results within 20 minutes across a growing menu of assays.
The cobas pure integrated solutions which combine clinical chemistry, immunoassay and Ion-Selective Electrode (ISE) diagnostic testing on a single platform for low- to mid-volume testing needs are also being highlighted at the meeting. Additionally, Roche is featuring the cobas eplex system, a rapid syndromic molecular diagnostic solution that has been updated with new features across all aspects of the workflow process, alongside the cobas 5800 is a compact, fully automated molecular PCR-testing solution with a comprehensive menu of assays. Visitors to the Roche booth can also experience the cobas LightCycler PRO qPCR system which is designed to deliver accuracy and flexibility to research and clinical diagnostic laboratories with an improved user experience.
At ADLM 2024, Roche is also presenting its full array of navify digital solutions, which securely integrate data across care settings, connecting the healthcare community and accelerating access to innovation and insights. Roche is also presenting eight Roche Idea Lab segments in its booth, where experts will discuss topics such as mass spectrometry, digital solutions, respiratory testing, and the use of high-medical-value assays when treating Alzheimer's and heart failure. Scientific industry workshops include "Laboratorians' Perspectives on Evaluation and Implementation of Alzheimer's CSF Assays" and "Making a Subjective Sepsis Diagnosis More Objective: The Role of AI-based Sepsis Medical Algorithms in Empowering Healthcare Decisions."
"Laboratorians strive to deliver trusted, timely test results to patients with greater effectiveness and efficiency. Our latest generation of cobas solutions are proven to deliver seamless integration of systems and data to support these efforts," said Brad Moore, president and CEO of Roche Diagnostics North America. "We are excited to share these next-generation solutions, which are the building blocks for future laboratories, and are eager to partner with our customers so that they can both do more with less and deliver the best possible outcomes for patients."
